Loading…
Aurigene Pharmaceutical Services, a subsidiary of Dr. Reddy's Laboratories, announced a $40 million investment to build a production facility for therapeutic proteins, antibodies and viral vectors at Genome Valley in Hyderabad, India. The facility is expected to be fully operational by the first half of 2024.